Endovascular Aneurysm Repair (EVAR) Market - Global Industry Research Analysis

According to Market Research Store, the global endovascular aneurysm repair (EVAR) market size was valued at around USD 2.39 billion in 2023 and is estimated to reach USD 4.21 billion by 2032, to register a CAGR of approximately 6.5% in terms of revenue during the forecast period 2024-2032.

To Get more Insights, Request a Free Sample

The endovascular aneurysm repair (EVAR) report provides a comprehensive analysis of the market, including its size, share, growth trends, revenue details, and other crucial information regarding the target market. It also covers the drivers, restraints, opportunities, and challenges till 2032.

Global Endovascular Aneurysm Repair (EVAR) Market: Overview

The Endovascular Aneurysm Repair (EVAR) Market centers on minimally invasive procedures and devices used to treat aneurysms in the abdominal and thoracic regions of the aorta. EVAR is a preferred alternative to open surgical repair as it involves the placement of a stent graft through the femoral artery, reducing recovery times and minimizing complications. This market includes thoracic endovascular aneurysm repair (TEVAR) devices and abdominal aortic aneurysm repair (AAA) devices.

The market is primarily driven by the increasing prevalence of aortic aneurysms due to aging populations, rising cases of hypertension, and other cardiovascular risk factors like smoking and obesity.

Additionally, advancements in imaging techniques, stent graft technology, and increased awareness of aneurysm management contribute to market growth. The growing demand for minimally invasive solutions and improved diagnostic capabilities have significantly enhanced treatment adoption rates.

Key Highlights

• The endovascular aneurysm repair (EVAR) market is anticipated to grow at a CAGR of 6.5% during the forecast period.
• The global endovascular aneurysm repair (EVAR) market was estimated to be worth approximately USD 2.39 billion in 2023 and is projected to reach a value of USD 4.21 billion by 2032.
• The growth of the endovascular aneurysm repair (EVAR) market is being driven by the increasing prevalence of aortic aneurysms, advancements in minimally invasive surgical techniques, and the rising preference for less invasive procedures.
• Based on the product, the abdominal aortic aneurysm (AAA) segment is growing at a high rate and is projected to dominate the market.
• On the basis of application, the hospitals segment is projected to swipe the largest market share.
• By region, North America is expected to dominate the global market during the forecast period.

Endovascular Aneurysm Repair (EVAR) Market: Dynamics

Key Growth Drivers

• Rising Prevalence of Aortic Aneurysm: The increasing incidence of aortic aneurysms, particularly in aging populations, is driving the demand for minimally invasive treatments like EVAR.
• Minimally Invasive Procedure: EVAR offers a less invasive alternative to open surgical repair, resulting in shorter hospital stays, reduced pain, and faster recovery.
• Technological Advancements: Continuous advancements in stent graft technology, imaging techniques, and procedural techniques have improved the safety and efficacy of EVAR.
• Aging Population: The aging population is more susceptible to vascular diseases, including aortic aneurysms, leading to increased demand for treatment.

Restraints

• High Procedure Costs: The initial cost of EVAR procedures, including the cost of devices and specialized equipment, can be significant.
• Technical Expertise: Performing EVAR requires specialized training and expertise, which may limit access to treatment in certain regions.
• Device-Related Complications: Potential complications, such as endoleaks and device migration, can occur and may require additional procedures.
• Patient Selection: Careful patient selection is crucial to ensure the suitability of EVAR and minimize complications.

Opportunities

• Minimally Invasive Techniques: Further advancements in minimally invasive techniques can improve patient outcomes and reduce recovery time.
• Novel Device Designs: The development of innovative device designs, such as self-expanding stents and bioresorbable scaffolds, can expand treatment options.
• Emerging Markets: Expanding into emerging markets with growing healthcare infrastructure can drive market growth.
• Telemedicine and Remote Monitoring: Utilizing telemedicine and remote monitoring technologies can improve patient care and reduce costs.

Challenges

• Regulatory Hurdles: Obtaining regulatory approval for new devices and procedures can be time-consuming and costly.
• Reimbursement Challenges: Securing adequate reimbursement for EVAR procedures can be complex.
• Long-Term Outcomes: Long-term follow-up studies are needed to assess the durability and safety of endovascular devices.
• Patient Education and Awareness: Increasing public awareness about aortic aneurysms and the benefits of early detection and treatment is crucial.

Endovascular Aneurysm Repair (EVAR) Market: Segmentation Insights

The global endovascular aneurysm repair (EVAR) market is divided by product, application, and region.

Segmentation Insights by Product

Based on Product, the global endovascular aneurysm repair (EVAR) market is divided into abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA), thoracoabdominal aortic aneurysm (TAAA), and others.

The Abdominal Aortic Aneurysm (AAA) dominates the EVAR market, accounting for the largest share due to its higher prevalence compared to thoracic or thoracoabdominal aneurysms. AA represents the largest segment in the EVAR market, primarily due to the higher prevalence of abdominal aortic aneurysms compared to other types.

The Thoracic Aortic Aneurysm (TAA) segment holds a significant share of the EVAR market, owing to the increasing incidence of thoracic aneurysms and advancements in TEVAR techniques. This segment addresses aneurysms occurring in the thoracic portion of the aorta. Thoracic Endovascular Aortic Repair (TEVAR) is the common method used, involving stent graft placement to prevent rupture or dissection.

Thoracoabdominal Aortic Aneurysm (TAAA) represents a smaller but rapidly growing segment within the EVAR market. The complexity of these cases makes it a niche segment, with high demand for advanced stent graft solutions. TAAA involves aneurysms affecting both the thoracic and abdominal segments of the aorta. These cases are more complex and require sophisticated EVAR devices tailored to individual anatomy.

Segmentation Insights by Application

On the basis of Application, the global endovascular aneurysm repair (EVAR) market is bifurcated into hospitals, ambulatory surgical centers, and others.

The Hospitals segment dominates the emerging display technology market due to the extensive use of advanced imaging and visualization tools in critical healthcare services. Hospitals account for the largest share of the application market, driven by their substantial investment in cutting-edge medical equipment and display systems to improve patient outcomes.

The Ambulatory Surgical Centers segment is growing rapidly, as these centers increasingly adopt advanced display solutions to offer high-quality care in a cost-effective and efficient manner. ASCs are specialized healthcare facilities focusing on outpatient surgical care. Emerging display technologies are used in surgical monitors, portable imaging devices, and patient management systems.

Endovascular Aneurysm Repair (EVAR) Market: Report Scope

Endovascular Aneurysm Repair (EVAR) Market: Regional Insights

• North America currently leads the global endovascular aneurysm repair (EVAR) market

North America dominates the EVAR market due to a well-established healthcare infrastructure, high prevalence of aortic aneurysms, and a strong focus on technological innovation. The United States accounts for the largest share in the region, driven by the high adoption of minimally invasive procedures, favorable reimbursement policies, and the presence of leading market players such as Medtronic, Cook Medical, and W. L. Gore & Associates. The growing aging population and increasing awareness of aneurysm screening programs also contribute to market growth.

Europe holds a significant market share, driven by the high prevalence of abdominal aortic aneurysms among its aging population and the widespread adoption of EVAR procedures in countries like Germany, the UK, France, and Italy. The region benefits from government-funded healthcare systems that support early diagnosis and treatment of aneurysms. Innovations in fenestrated and branched stent grafts, as well as clinical research advancements, further enhance the adoption of EVAR technologies in the region.

The Asia Pacific region is the fastest-growing market for EVAR devices, owing to its large aging population, rising healthcare expenditure, and growing awareness about aneurysm treatments. Countries like China, Japan, South Korea, and India are driving growth. Japan leads in innovation and early adoption of advanced EVAR solutions, while China and India are witnessing increased procedural volumes due to improved healthcare infrastructure and access. Additionally, medical tourism in Asia Pacific boosts the adoption of EVAR, as patients seek cost-effective, high-quality treatment options.

The Latin American EVAR market is growing steadily, with Brazil and Mexico being key contributors. The rising prevalence of risk factors like hypertension and smoking, combined with improving healthcare infrastructure, supports market growth. However, the high cost of EVAR devices and limited access to advanced technologies in some regions present challenges. Government initiatives to improve vascular care and awareness about minimally invasive options are expected to boost growth in the coming years.

The Middle East and Africa (MEA) region is experiencing gradual growth in the EVAR market, particularly in countries like Saudi Arabia, the UAE, and South Africa. Factors such as rising healthcare investments, increasing prevalence of cardiovascular diseases, and a focus on improving medical infrastructure are driving market growth. However, limited awareness and accessibility in many African nations remain barriers to widespread adoption. Efforts to improve healthcare accessibility and attract medical device manufacturers to the region are expected to support future growth.

Recent Developments:

• In October 2021, in the nation of Japan, Terumo Aortic disclosed that their Treo Abdominal Aortic Stent Grafts system had been granted regulatory approval. For the treatment of patients with abdominal aortic aneurysms, the Treo device has been approved by the Japanese Pharmaceuticals and Medical Devices Agency. The device offers both suprarenal and infrarenal fixation, despite the challenges of stent migration and endoleaks associated with the use of stents and grafts.
• In October 2021, Sanford Health has announced that the FDA has conferred Breakthrough Device designation to an investigational aortic stent graft system for the treatment of thoracoabdominal aortic aneurysms (TAAAs) that was developed by vascular surgeon Patrick Kelly, MD. Its mobile limb technology is not inhibited by anatomy and is well-suited to tortuosity, which may make it suitable for use in cases where previous repairs have failed. No custom construct time, intricate wires, or procedural steps are necessary for the system.
• In September 2021, the custom-made thoracoabdominal hybrid device, which is intended to treat thoracoabdominal aortic disease, has been successfully implanted in the first human. This announcement was made by Terumo Aortic. This is a significant advancement in the field of minimally invasive interventions. The technology has been developed from the company's existing portfolio, which minimizes the likelihood of complications following the intervention. In conclusion, it commences their voyage into the realm of providing customized solutions.

Endovascular Aneurysm Repair (EVAR) Market: Competitive Landscape

The report provides an in-depth analysis of companies operating in the endovascular aneurysm repair (EVAR) market, including their geographic presence, business strategies, product offerings, market share, and recent developments. This analysis helps to understand market competition.

Some of the major players in the global endovascular aneurysm repair (EVAR) market include:

• Medtronic (Endurant)
• TriVascular (Ovation Xi)
• Lombard Medical (Aorfix)

The global endovascular aneurysm repair (EVAR) market is segmented as follows:

By Product

• Abdominal Aortic Aneurysm (AAA)
• Thoracic Aortic Aneurysm (TAA)
• Thoracoabdominal Aortic Aneurysm (TAAA)

By Application

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• The Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East Africa

Frequently Asked Questions